To test this hypothesis, we generated ovarian cancer cell lines with high and low HE4 expression and showed that the up- or downregulation of HE4 was accompanied by parallel changes in ANXA2 expression in the treated cell lines. This evidence concerns the gene WFDC2 and ovarian cancer.